Kexing Biopharm Co., Ltd. (688136.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.23B |
| Enterprise Value | 6.48B |
| P/E Ratio | 17.58 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 2.6 |
| Price/Book Ratio | 2.05 |
| Enterprise/Revenue | 3.28 |
| Enterprise/EBITDA | 82.7 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 1.54B |
| Revenue/Share | 7.29 |
| Gross Profit | 1.54B |
| EBITDA | 255.5M |
| Net Income | 159.44M |
| Diluted EPS | 0.81 |
Balance Sheet
| Total Cash | 609.87M |
| Total Cash/Share | 3.07 |
| Total Debt | 1.5B |
| Total Debt/Equity | 0.82 |
| Current Ratio | 1.34 |
| Book Value Per Share | 9.26 |
Price History
| 52-Week Change | -53.56 |
| 52-Week High | 44.31 |
| 52-Week Low | 17 |
| Moving Average 50 Days | 20.26 |
| Moving Average 200 Days | 26.35 |
Statistics
| Average Volume | 7.65M |
| Shares Outstanding | 198.59M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 1.32 |
| Payout Ratio | 0.38 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
